Docon Technologies Private Limited
Thyrocare Technologies Limited · NSE
7,94,69,696 sh · ₹4,916.00 Cr
Nippon India Small Cap Fund
0.4% of their portfolio
₹299.22 Cr
51,67,803 sh
Nippon India Pharma Fund
2.5% of their portfolio
₹232.56 Cr
40,16,627 sh
HSBC Mutual Fund
Investor
₹187.18 Cr
89,99,193 sh
Aditya Birla Sun Life ELSS Tax Saver Fund
1.3% of their portfolio
₹183.94 Cr
33,48,570 sh
Kotak Mahindra Life Insurance Company Limited
Investor
₹149.76 Cr
48,00,000 sh
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
1.9% of their portfolio
₹132.39 Cr
22,86,558 sh
ICICI Prudential Dividend Yield Equity Fund
1.8% of their portfolio
₹124.01 Cr
21,41,720 sh
ICICI Prudential Innovation Fund
1.1% of their portfolio
₹84.25 Cr
14,55,153 sh
DSP Mutual Fund
Investor
₹82.45 Cr
26,42,726 sh
ICICI Prudential Multicap Fund
0.4% of their portfolio
₹69.00 Cr
11,91,703 sh
HBM Healthcare Investments (Cayman) Ltd
Investor
₹47.49 Cr
7,61,000 sh
HDFC Pharma and Healthcare Fund
1.4% of their portfolio
₹41.64 Cr
7,19,111 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Docon Technologies Private Limited
Thyrocare Technologies Limited · NSE
7,94,69,696 sh · ₹4,916.00 Cr
Docon Technologies Private Limited
Thyrocare Technologies Limited · NSE
+7,94,69,696 sh
Docon Technologies Private Limited
Thyrocare Technologies Limited · NSE
+1,75,00,000 sh
ICICI Prudential Mutual Fund
Thyrocare Technologies Limited · NSE
−32,62,621 sh
Docon Technologies Private Limited
Thyrocare Technologies Limited · NSE
−1,57,69,696 sh
HSBC Mutual Fund
Thyrocare Technologies Limited · NSE
+29,99,731 sh
Catalyst Trusteeship Limited
Thyrocare Technologies Limited · NSE
−1,75,00,000 sh
Docon Technologies Private Limited
Thyrocare Technologies Limited · NSE
Docon Technologies Private Limited
Thyrocare Technologies Limited · NSE
−1,75,00,000 sh
Docon Technologies Private Limited
Thyrocare Technologies Limited · NSE
−16,01,039 sh · ₹100.97 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
22 announcements on record for this company.
Promoter holding by quarter: Jun 2025 71.1%, Sep 2025 71.1%, Dec 2025 60.9%, Mar 2026 60.9%. Dec 2024, Mar 2025: no filing.
FII
— +0.4pp
FII holding by quarter: Jun 2025 3.2%, Sep 2025 4.8%, Dec 2025 5.0%, Mar 2026 5.4%. Dec 2024, Mar 2025: no filing.
DII
— +0.5pp
DII holding by quarter: Jun 2025 14.5%, Sep 2025 13.5%, Dec 2025 20.5%, Mar 2026 21.0%. Dec 2024, Mar 2025: no filing.
MF
— +0.8pp
MF holding by quarter: Jun 2025 12.7%, Sep 2025 11.9%, Dec 2025 18.6%, Mar 2026 19.4%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 71.1%, Sep 2025 71.1%, Dec 2025 60.9%, Mar 2026 60.9%. Dec 2024, Mar 2025: no filing.
FII
— +0.4pp
FII holding by quarter: Jun 2025 3.2%, Sep 2025 4.8%, Dec 2025 5.0%, Mar 2026 5.4%. Dec 2024, Mar 2025: no filing.
DII
— +0.5pp
DII holding by quarter: Jun 2025 14.5%, Sep 2025 13.5%, Dec 2025 20.5%, Mar 2026 21.0%. Dec 2024, Mar 2025: no filing.
MF
— +0.8pp
MF holding by quarter: Jun 2025 12.7%, Sep 2025 11.9%, Dec 2025 18.6%, Mar 2026 19.4%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
22 announcements on record for this company.